United States:
Beware: Private Equity Firms Facing Heightened False Claims Act And Antitrust Risks (Video)
11 May 2023
Sheppard Mullin Richter & Hampton
To print this article, all you need is to be registered or login on Mondaq.com.
It is more important than ever for private equity firms to be
proactive with efforts to mitigate emerging False Claims Act (FCA)
and antitrust risks. As the government tries to protect the
Medicare trust fund from insolvency, and whistleblowers seek
financial windfalls from investors with "deeper pockets,"
private equity firms need new strategies to protect their capital
as they face increased exposure to potentially catastrophic FCA and
antitrust liability through targeted investigations and lawsuits.
Please join us as we discuss recent enforcement trends and how best
to manage this new level of risk.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Corporate/Commercial Law from United States
Corporate Transparency Act Update
Shulman Rogers
With the arrival of spring and the first set of Corporate Transparency Act (CTA) filing deadlines behind us, it is a good time for an update on lessons learned from the initial filings.
Compliance Isn't The Only 'AI Washing' Risk
Bracewell
Companies are rapidly adopting artificial intelligence technologies, and both regulators and private plaintiffs have set their sights on "AI washing," where businesses tout AI capabilities that do not exist.